1108 related articles for article (PubMed ID: 17480225)
21. The pathophysiology of paraneoplastic neurological syndromes.
Liblau R; Benyahia B; Delattre JY
Ann Med Interne (Paris); 1998 Dec; 149(8):512-20. PubMed ID: 10021905
[TBL] [Abstract][Full Text] [Related]
22. [Paraneoplastic peripheral neuropathies].
Antoine JC;
Rev Neurol (Paris); 2008 Dec; 164(12):1068-72. PubMed ID: 18848341
[TBL] [Abstract][Full Text] [Related]
23. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
24. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
Dalmau J; Porta-Etessam J
Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
[TBL] [Abstract][Full Text] [Related]
25. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
[TBL] [Abstract][Full Text] [Related]
26. [Neurologic paraneoplastic syndromes and anti-neuronal antibodies].
Mygland A
Tidsskr Nor Laegeforen; 1996 Jan; 116(3):361-5. PubMed ID: 8638263
[TBL] [Abstract][Full Text] [Related]
27. Paraneoplastic syndromes in ophthalmology.
Bussat A; Langner-Lemercier S; Salmon A; Mouriaux F
J Fr Ophtalmol; 2018 May; 41(5):e181-e185. PubMed ID: 29784239
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune pathogenesis of paraneoplastic neurological syndromes.
Anderson NE; Cunningham JM; Posner JB
Crit Rev Neurobiol; 1987; 3(3):245-99. PubMed ID: 3315239
[TBL] [Abstract][Full Text] [Related]
29. Navigating the paraneoplastic neurological syndromes.
Giannopoulou C
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):333-8. PubMed ID: 12722733
[No Abstract] [Full Text] [Related]
30. [Pathology of paraneoplastic syndromes of the central and peripheral nervous systems and muscle ].
Ferrer I
Rev Neurol; 2000 Dec 16-31; 31(12):1228-36. PubMed ID: 11211860
[TBL] [Abstract][Full Text] [Related]
31. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
[TBL] [Abstract][Full Text] [Related]
32. [Diagnosis and management of paraneoplastic neurological syndromes].
Saji E; Kawachi I; Nishizawa M
Brain Nerve; 2010 Apr; 62(4):319-30. PubMed ID: 20420171
[TBL] [Abstract][Full Text] [Related]
33. [Paraneoplastic syndromes: a review].
Berardi R; Grilli G; Romagnoli E; Saladino T; Freddari F; Tamburrano T; Galizia E; Carbonari G; Mariani C; Braconi C; Pierantoni C; Battelli N; Scartozzi M; Cascinu S
Clin Ter; 2005; 156(6):281-8. PubMed ID: 16463565
[TBL] [Abstract][Full Text] [Related]
34. [Paraneoplastic neurological syndromes].
Didelot A; Honnorat J
Rev Med Interne; 2011 Oct; 32(10):605-11. PubMed ID: 21036427
[TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic disorders of the central and peripheral nervous systems.
Didelot A; Honnorat J
Handb Clin Neurol; 2014; 121():1159-79. PubMed ID: 24365410
[TBL] [Abstract][Full Text] [Related]
36. Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
Rozsa C; Vincent A; Aranyi Z; Kovacs GG; Komoly S; Illes Z
Ideggyogy Sz; 2008 Sep; 61(9-10):325-8. PubMed ID: 18841652
[TBL] [Abstract][Full Text] [Related]
37. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
38. [Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].
Honnorat J
Bull Acad Natl Med; 2014 Feb; 198(2):243-54; discussion 255. PubMed ID: 26263702
[TBL] [Abstract][Full Text] [Related]
39. Paraneoplastic effects on neurophthalmologic function.
Ray D; Nigam A
Otol Neurotol; 2007 Sep; 28(6):860-2. PubMed ID: 17558343
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
